|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3800 USD | -28.30% |
|
-28.27% | -15.56% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.88M 1.76M 1.62M 3.05M 207M 3.08M 20.63M 8.1M 103M 8.17M 7.99M 343M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.68M 10.88M 10.01M 18.9M 1.28B 19.11M 128M 50.2M 641M 50.64M 49.52M 2.12B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -28.30% | ||
| 1 week | -28.27% | ||
| Current month | -28.27% | ||
| 1 month | -21.90% | ||
| 3 months | -2.34% | ||
| 6 months | -24.75% | ||
| Current year | -15.56% |
| 1 week | 0.38 |  | 0.53 |
| 1 month | 0.38 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.30% | -28.27% | +2.70% | -59.10% | 3.84M | |
| +4.86% | -3.32% | +52.73% | +160.26% | 1,043B | |
| +1.04% | -2.99% | +50.87% | +52.38% | 621B | |
| +0.98% | -6.49% | +24.00% | +66.66% | 435B | |
| +1.96% | +0.83% | +42.80% | +37.60% | 361B | |
| -0.11% | -4.07% | +30.37% | +39.73% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.32% | 251B | |
| +4.57% | +5.21% | +35.91% | +67.64% | 220B | |
| -4.32% | -12.94% | -3.79% | -44.56% | 201B | |
| -2.58% | -0.73% | +17.16% | +67.46% | 164B | |
| Average | -2.36% | -3.43% | +26.00% | +39.84% | 358.91B | |
| Weighted average by Cap. | +0.77% | -3.79% | +37.10% | +76.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 19.98M 18.63M 17.13M 32.34M 2.19B 32.7M 219M 85.91M 1.1B 86.65M 84.74M 3.64B | 24.22M 20.97M 19.55M 17.98M 33.95M 2.3B 34.32M 230M 90.17M 1.15B 90.95M 88.94M 3.82B |
| Net income | -5.27M -4.56M -4.25M -3.91M -7.38M -501M -7.47M -49.97M -19.61M -251M -19.78M -19.35M -830M | -3.2M -2.77M -2.59M -2.38M -4.49M -305M -4.54M -30.39M -11.93M -152M -12.03M -11.76M -505M |
| Net Debt | 10.2M 8.83M 8.23M 7.57M 14.29M 970M 14.45M 96.74M 37.97M 485M 38.3M 37.45M 1.61B | 11.31M 9.79M 9.13M 8.4M 15.85M 1.08B 16.03M 107M 42.1M 538M 42.47M 41.53M 1.78B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | $0.5298 | -.--% | 811 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
